Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Protagenic Therapeutics, Inc. - Common Stock
(NQ:
PTIX
)
1.300
-0.060 (-4.41%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Protagenic Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
12 Health Care Stocks Moving In Friday's Intraday Session
↗
October 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
October 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
September 30, 2024
Via
Benzinga
Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket
↗
September 16, 2024
Via
Benzinga
Protagenic Therapeutics’ Innovative Peptide PT00114 to be Highlighted at Boston Summit
April 17, 2024
Via
ACCESSWIRE
Protagenic Therapeutics Reports Fourth Quarter and Full Year 2023 Results
April 01, 2024
Via
ACCESSWIRE
Protagenic Therapeutics Successfully Concludes Third Cohort in Single Dose Portion of Phase 1 Trial for Stress-Related Neuropsychiatric Disorders
March 27, 2024
Via
ACCESSWIRE
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
↗
September 12, 2024
Via
Benzinga
PTIX Stock Earnings: Protagenic Therapeutics Reported Results for Q2 2024
↗
August 15, 2024
Protagenic Therapeutics just reported results for the second quarter of 2024.
Via
InvestorPlace
PTIX Stock Earnings: Protagenic Therapeutics Reported Results for Q1 2024
↗
June 25, 2024
Protagenic Therapeutics just reported results for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
May 23, 2024
Via
Benzinga
Protagenic Therapeutics' Stress-Regulating Peptide Demonstrates Exceptional Safety in Single Dose Portion of Phase I Trial, Paving the Way for Next Steps Toward Potential Breakthrough Treatments in Stress Related Neuropsychiatric Disorders
May 22, 2024
Via
ACCESSWIRE
Protagenic Therapeutics Schedules First Q4 and FY 2023 Earnings Call
March 25, 2024
Via
ACCESSWIRE
Protagenic Therapeutics Achieves First Clinical Safety Milestone with its Novel Neuropeptide for the Potential Treatment of Stress-Related Disorders
February 13, 2024
Via
ACCESSWIRE
Protagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114
September 26, 2023
Via
ACCESSWIRE
Protagenic Therapeutics Completes Enrollment in Single Dose Portion of Phase 1 of Innovative Stress Disorder Trial
May 01, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
April 26, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
April 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
April 23, 2024
Via
Benzinga
PTIX Stock Earnings: Protagenic Therapeutics Reported Results for Q4 2023
↗
April 01, 2024
Protagenic Therapeutics just reported results for the fourth quarter of 2023.
Via
InvestorPlace
Protagenic Therapeutics to Effect 1-for-4 Reverse Stock Split
March 22, 2023
Via
ACCESSWIRE
Earnings Scheduled For April 1, 2024
↗
April 01, 2024
Companies Reporting Before The Bell • Mach Natural Resources (NYSE:MNR) is projected to report quarterly earnings at $0.92 per share on revenue of $213.43 million.
Via
Benzinga
Protagenic Therapeutics Announces Resolution of Nasdaq Deficiency Notice
March 21, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
March 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
December 13, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
October 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
October 04, 2023
Via
Benzinga
Why Block Shares Are Trading Lower By Over 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
March 23, 2023
Gainers DiamondHead Holdings Corp. (NASDAQ: DHHC) shares jumped 104.2% to $21.15. DiamondHead entered into convertible note purchase agreement dated March 21, 2023.
Via
Benzinga
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session
↗
December 30, 2022
Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
↗
December 29, 2022
On Thursday, 116 companies set new 52-week lows.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
